3-30800968-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_207359.3(GADL1):āc.1171T>Cā(p.Phe391Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000638 in 1,613,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00034 ( 0 hom., cov: 31)
Exomes š: 0.000035 ( 0 hom. )
Consequence
GADL1
NM_207359.3 missense
NM_207359.3 missense
Scores
2
3
14
Clinical Significance
Conservation
PhyloP100: 4.99
Genes affected
GADL1 (HGNC:27949): (glutamate decarboxylase like 1) Predicted to enable aspartate 1-decarboxylase activity; pyridoxal phosphate binding activity; and sulfinoalanine decarboxylase activity. Predicted to be involved in carboxylic acid metabolic process. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04375145).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GADL1 | NM_207359.3 | c.1171T>C | p.Phe391Leu | missense_variant | 12/15 | ENST00000282538.10 | NP_997242.2 | |
GADL1 | XM_017006297.2 | c.1114T>C | p.Phe372Leu | missense_variant | 12/15 | XP_016861786.1 | ||
GADL1 | XM_047448071.1 | c.1171T>C | p.Phe391Leu | missense_variant | 12/14 | XP_047304027.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GADL1 | ENST00000282538.10 | c.1171T>C | p.Phe391Leu | missense_variant | 12/15 | 5 | NM_207359.3 | ENSP00000282538 | P1 | |
GADL1 | ENST00000454381.3 | c.1171T>C | p.Phe391Leu | missense_variant | 12/12 | 1 | ENSP00000427059 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152138Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
52
AN:
152138
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251346Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135848
GnomAD3 exomes
AF:
AC:
19
AN:
251346
Hom.:
AF XY:
AC XY:
6
AN XY:
135848
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461626Hom.: 0 Cov.: 34 AF XY: 0.0000316 AC XY: 23AN XY: 727112
GnomAD4 exome
AF:
AC:
51
AN:
1461626
Hom.:
Cov.:
34
AF XY:
AC XY:
23
AN XY:
727112
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000342 AC: 52AN: 152256Hom.: 0 Cov.: 31 AF XY: 0.000349 AC XY: 26AN XY: 74456
GnomAD4 genome
AF:
AC:
52
AN:
152256
Hom.:
Cov.:
31
AF XY:
AC XY:
26
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
6
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
14
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2022 | The c.1171T>C (p.F391L) alteration is located in exon 12 (coding exon 12) of the GADL1 gene. This alteration results from a T to C substitution at nucleotide position 1171, causing the phenylalanine (F) at amino acid position 391 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;.
Vest4
MutPred
Loss of methylation at K392 (P = 0.0513);Loss of methylation at K392 (P = 0.0513);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at